Get startedLog in
    Picture of Evome Medical Technologies logo

    EVMT — Evome Medical Technologies Cashflow Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareSpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Evome Medical Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

    2020
    February 29th
    R2021
    February 28th
    2022
    February 28th
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M10 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-2.34-2.67-4.37-15.9-15.6
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items0.8650.4220.14614.213.1
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital1.291.27-0.2062.8-0.925
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Cash from Operating Activities-0.128-0.975-3.7-0.219-0.919
    Capital Expenditures—0-0.055-0.883-0.203
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-0.8990.075-4.56-4.71-1.32
    Acquisition of Business
    Sale of Business
    Sale/Maturity of Investment
    Purchase of Investments
    Cash from Investing Activities-0.8990.075-4.62-5.6-1.52
    Financing Cash Flow Items—0-0.660.986—
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities—5.433.94-0.220.825
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-0.9544.16-4.45-6.13-1.01